PreveCeutical Medical Inc. (CSE:PREV)

Market Cap	29.34M
Revenue (ttm)	n/a
Net Income (ttm)	-2.60M
Shares Out	586.81M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,607,553
Average Volume	632,999
Open	0.0600
Previous Close	0.0550
Day's Range	0.0500 - 0.0600
52-Week Range	0.0150 - 0.0550
Beta	0.05
RSI	64.68
Earnings Date	Nov 28, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; and BSV Peptide Program that targets cancer progression. The company is headquartered in West Vancou...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV